108 related articles for article (PubMed ID: 21996111)
21. Non-bladder cancer mortality in patients with urothelial cancer of the bladder.
Scosyrev E; Wu G; Golijanin D; Messing E
Urol Oncol; 2013 Jul; 31(5):656-63. PubMed ID: 21550827
[TBL] [Abstract][Full Text] [Related]
22. Risk of concomitant carcinoma in situ determining biopsy candidates among primary non-muscle-invasive bladder cancer patients: retrospective analysis of 173 Japanese cases.
Hara T; Takahashi M; Gondo T; Nagao K; Ohmi C; Sakano S; Naito K; Matsuyama H
Int J Urol; 2009 Mar; 16(3):293-8. PubMed ID: 19207607
[TBL] [Abstract][Full Text] [Related]
23. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
[TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer.
Sandhu JS; Vickers AJ; Bochner B; Donat SM; Herr HW; Dalbagni G
BJU Int; 2006 Jul; 98(1):59-62. PubMed ID: 16626308
[TBL] [Abstract][Full Text] [Related]
25. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
[TBL] [Abstract][Full Text] [Related]
26. [TNM-oriented therapy planning in bladder cancer].
Goepel M; Rübben H
Urologe A; 1991 May; 30(3):151-7. PubMed ID: 1871932
[TBL] [Abstract][Full Text] [Related]
27. Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases.
Capitanio U; Shariat SF; Isbarn H; Weizer A; Remzi M; Roscigno M; Kikuchi E; Raman JD; Bolenz C; Bensalah K; Koppie TM; Kassouf W; Fernández MI; Ströbel P; Wheat J; Zigeuner R; Langner C; Waldert M; Oya M; Guo CC; Ng C; Montorsi F; Wood CG; Margulis V; Karakiewicz PI
Eur Urol; 2009 Jul; 56(1):1-9. PubMed ID: 19361911
[TBL] [Abstract][Full Text] [Related]
28. A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends.
Koay EJ; Teh BS; Paulino AC; Butler EB
Cancer; 2011 Dec; 117(23):5325-33. PubMed ID: 21567387
[TBL] [Abstract][Full Text] [Related]
29. Patterns of care for the treatment of bladder cancer.
Snyder C; Harlan L; Knopf K; Potosky A; Kaplan R
J Urol; 2003 May; 169(5):1697-701. PubMed ID: 12686811
[TBL] [Abstract][Full Text] [Related]
30. Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer.
Isbarn H; Karakiewicz PI; Shariat SF; Capitanio U; Palapattu GS; Sagalowsky AI; Lotan Y; Schoenberg MP; Amiel GE; Lerner SP; Sonpavde G
J Urol; 2009 Aug; 182(2):459-65; discussion 465. PubMed ID: 19524971
[TBL] [Abstract][Full Text] [Related]
31. [BCG versus photodynamic therapy (PDT) for nonmuscle invasive bladder cancer-a multicentre clinical phase III study].
Jocham D; von Wietersheim J; Pflüger H; Steiner H; Doehn C; Büttner H; Böhle A; Kausch I
Aktuelle Urol; 2009 Mar; 40(2):91-9. PubMed ID: 19214951
[TBL] [Abstract][Full Text] [Related]
32. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
[TBL] [Abstract][Full Text] [Related]
33. TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy for muscle-invasive bladder cancer.
Qureshi KN; Griffiths TR; Robinson MC; Marsh C; Roberts JT; Hall RR; Lunec J; Neal DE
Clin Cancer Res; 1999 Nov; 5(11):3500-7. PubMed ID: 10589764
[TBL] [Abstract][Full Text] [Related]
34. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
[TBL] [Abstract][Full Text] [Related]
35. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
[TBL] [Abstract][Full Text] [Related]
36. Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy?
Weiss C; Wolze C; Engehausen DG; Ott OJ; Krause FS; Schrott KM; Dunst J; Sauer R; Rödel C
J Clin Oncol; 2006 May; 24(15):2318-24. PubMed ID: 16710030
[TBL] [Abstract][Full Text] [Related]
37. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
38. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
[TBL] [Abstract][Full Text] [Related]
39. Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population.
Schrag D; Mitra N; Xu F; Rabbani F; Bach PB; Herr H; Begg CB
Urology; 2005 Jun; 65(6):1118-25. PubMed ID: 15922428
[TBL] [Abstract][Full Text] [Related]
40. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic study of 51 cases.
Lee TK; Miyamoto H; Osunkoya AO; Guo CC; Weiss SW; Epstein JI
Am J Surg Pathol; 2010 Apr; 34(4):502-9. PubMed ID: 20154594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
